This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: John David Hayler: Innovator in Pharmaceutical Processes
Introduction
John David Hayler is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel processes for preparing complex chemical compounds. His work is recognized for its potential applications in medicinal chemistry.
Latest Patents
Hayler holds a patent for "Processes for preparing 2-(6-(1H-indol-4-yl)-1H-indazol-4-yl)-5-((4-isopropylpiperazin-1-yl)methyl)oxazole." This invention provides innovative methods for synthesizing compounds of formula (IV) and their salts, along with novel intermediates and a unique salt and polymorph. His patent represents a significant advancement in the preparation of pharmaceutical compounds.
Career Highlights
John David Hayler is associated with GlaxoSmithKline Intellectual Property Development Limited, where he applies his expertise in chemical processes. His work has contributed to the advancement of pharmaceutical research and development, showcasing his commitment to innovation in the industry.
Collaborations
Hayler has collaborated with esteemed colleagues, including Robert Nicholas Bream and Alan Geoffrey Ironmonger. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical processes.
Conclusion
John David Hayler's contributions to the field of pharmaceuticals through his innovative patent and collaborations highlight his role as a key inventor in the industry. His work continues to influence the development of new medicinal compounds.